Industry News

The Massachusetts Institute of Technology is planning to build the Schwarzman College of Computing in Cambridge. Accommodating programs in artificial intelligence (AI) and machine learning, the interdisciplinary facility is supported by $1 billion in funding, which includes an endowment for the creation of 50 new faculty positions and the development of computing resources across the university. The project is expected to provide between 150,000 and 165,000 sf of laboratory and office space to house 65 faculty members, their research groups, and affiliated staff.

The University of Illinois broke ground in October of 2018 on a $41 million renovation and expansion of the Mechanical Engineering Building in Urbana. The project includes construction of a five-story, 25,000-sf addition and extensive renovations of the existing 60,000-sf structure. The completed facility will offer active-learning classrooms, integrated teaching and project labs, a 3,000-sf student design center, meeting and event areas, a café, and 7,000 sf of maker space. Occupancy is expected in fall of 2021. 

TRIUMF, Canada's national particle accelerator laboratory, is planning to build the 269,000-sf Institute for Advanced Medical Isotopes (IAMI) in Vancouver. The project will support interdisciplinary radioisotope and radiopharmaceutical research by bringing together TRIUMF faculty and students with academic, government, and industry partners. Supporting the creation of next-generation cancer therapies and imaging technologies, the nuclear medicine facility will house a TR-24 medical cyclotron, research labs, control rooms, and offices.

The University of Melbourne began construction in October of 2018 on Melbourne Connect, a AUD$425 million innovation precinct. Created in partnership with a development consortium steered by Lendlease, the 800,000-sf project will include a fabrication lab, student accommodation, commercial offices, a co-working center, retail amenities, and space for Science Gallery Melbourne. Designed by Woods Bagot, the mixed-use complex will comprise five buildings connected by a 35,000-sf superfloor and a central public outdoor garden.

WuXi Biologics began construction in October of 2018 on its Manufacturing Center of Excellence in Shijiazhuang, China. Providing 48,000 liters of production capacity, the facility will meet international cGMP standards and will utilize disposable bioreactors. WuXi Biologics expects to have over 220,000 liters of manufacturing capacity by 2021.